Chen Jing, Wang Yina, Wang Jingyi, Chen Lie, Luo Qiushi, Wang Bei, He Xingwei, Li Xuefei, Zuo Huakun, Zuo Ping, Yang Xiaoyun
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Cardiovasc Med. 2022 Sep 28;9:948347. doi: 10.3389/fcvm.2022.948347. eCollection 2022.
Electrocardiography (ECG) plays a very important role in various cardiovascular diseases and elevated D-dimer in serum associated with thrombosis. In patients with coronavirus disease 2019 (COVID-19), immense pieces of evidence showed that ECG abnormalities or elevated D-dimer in serum occurred frequently. However, it remains unclear whether ECG abnormalities combined with elevated D-dimer could be a new risk predictor in patients with COVID-19.
This retrospective cohort study enrolled 416 patients with COVID-19 at Wuhan Tongji Hospital from 1 February to 20 March 2020. ECG manifestations, D-dimer levels, and in-hospital deaths were recorded for all patients. Logistic regression analysis was performed to examine the association between ECG manifestations and in-hospital mortality in patients with elevated D-dimer levels. In patients hospitalized for COVID-19, ST-T abnormalities (34.3%) were the most frequent ECG manifestations, whereas sinus tachycardia (ST) (13.3%) and atrial arrhythmias with rapid rhythms (8.5%) were the two most common cardiac arrhythmias. Compared to severely ill patients with COVID-19, ST-T abnormalities, ST and atrial arrhythmias (<0.001) with rapid rhythms, D-dimer levels, and in-hospital deaths were significantly more frequent in critically ill patients with COVID-19. Moreover, elevated D-dimer levels were observed in all the patients who died. In the subgroup of 303 patients with elevated serum D-dimer levels, the patient's age, the incidence of ST-T abnormalities, ST, atrial fibrillation (AF), and atrial premature beat were significantly higher than those in the non-elevated D-dimer subgroup. Multivariate logistic regression analysis further revealed that ST and AF were risk factors for in-hospital mortality in COVID-19 patients with elevated D-dimer levels.
ECG abnormalities and elevated D-dimer levels were associated with a higher risk of critical illness and death in patients hospitalized for COVID-19. ECG abnormalities, including ST and AF, combined with elevated D-dimer levels, can be used to predict death in COVID-19.
心电图(ECG)在各种心血管疾病以及与血栓形成相关的血清D-二聚体升高方面发挥着非常重要的作用。在2019冠状病毒病(COVID-19)患者中,大量证据表明心电图异常或血清D-二聚体升高频繁出现。然而,心电图异常与D-二聚体升高是否可作为COVID-19患者的一种新的风险预测指标仍不清楚。
这项回顾性队列研究纳入了2020年2月1日至3月20日在武汉同济医院住院的416例COVID-19患者。记录所有患者的心电图表 现、D-二聚体水平和院内死亡情况。进行逻辑回归分析,以检验D-二聚体水平升高患者的心电图表 现与院内死亡率之间的关联。在因COVID-19住院的患者中,ST-T异常(34.3%)是最常见的心电图表 现,而窦性心动过速(ST)(13.3%)和快速型房性心律失常(8.5%)是两种最常见的心律失常。与COVID-1重症患者相比,COVID-19危重症患者的ST-T异常、ST和快速型房性心律失常(<0.001)、D-二聚体水平及院内死亡更为常见。此外,所有死亡患者均观察到D-二聚体水平升高。在血清D-二聚体水平升高的303例患者亚组中,患者年龄、ST-T异常、ST、心房颤动(AF)和房性早搏的发生率显著高于D-二聚体水平未升高的亚组。多因素逻辑回归分析进一步显示,ST和AF是D-二聚体水平升高的COVID-19患者院内死亡的危险因素。
心电图异常和D-二聚体水平升高与COVID-19住院患者的重症及死亡风险较高相关。包括ST和AF在内的心电图异常与D-二聚体水平升高相结合,可用于预测COVID-19患者的死亡。